Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Ingenol derivatives as anti-HIV agents

Oct. 11, 1996

Merck & Co. cleared to market protease inhibitor in EU

Oct. 11, 1996

Anti-HIV agents from Nippon Paper

Oct. 11, 1996

EU approval for Roche AIDS drug

Oct. 11, 1996

Anti-HIV agents from Department of Health & Human Services

Oct. 11, 1996

Gilead Sciences issues warning regarding Vistide

Oct. 4, 1996

Japanese patent coverage for NABI HIV immunotherapeutic

Oct. 4, 1996

New agent for CMV infection from Glaxo Wellcome

Oct. 4, 1996

Pharmacia & Upjohn details the activity of new HIV protease inhibitor

Oct. 4, 1996

CMV protease structure reported by three different pharmaceutical companies

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...